Non-feminizing estrogens: A novel neuroprotective therapy

Molecular and Cellular Endocrinology

Volumn 389, Issue 1-2, 2014, Pages 40-47

  Petrone, Ashley B ^a,c   Gatson, Joshua W ^b   Simpkins, James W ^a,c   Reed, Miranda N ^c  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; Estradiol; Estrogen receptors; Neuroprotection; Non feminizing estrogens; Traumatic brain injury

Indexed keywords

17ALPHA ESTRADIOL; ESTRADIOL; ESTROGEN; ESTROGEN DERIVATIVE; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; G 1; GENISTEIN; HORMONE RECEPTOR STIMULATING AGENT; PLACEBO; UNCLASSIFIED DRUG; ESTROGEN RECEPTOR; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; BRAIN ISCHEMIA; CELL PROTECTION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG TARGETING; FRIEDREICH ATAXIA; HUMAN; IC 50; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; STRUCTURE ACTIVITY RELATION; TRAUMATIC BRAIN INJURY; ANIMAL; BRAIN; CLINICAL TRIAL (TOPIC); DRUG EFFECTS; FEMALE; MALE; METABOLISM;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CLINICAL TRIALS AS TOPIC; ESTROGENS; FEMALE; HUMANS; MALE; NEUROPROTECTIVE AGENTS; RECEPTORS, ESTROGEN;

EID: 84901491465     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2013.12.017     Document Type: Review

References (93)

1. Aisen P.S. Alzheimer's disease therapeutic research: the path forward. Alzheimer's Res. Ther. 2009, 1(1). Online Only.
2. Alkayed N.J., Goto S., Sugo N., Joh H.D., Klaus J., Crain B.J., Bernard O., Traystman R.J., Hurn P.D. Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke. J. Neurosci. 2001, 21:7543-7550.
3. Alvarez-de-la-Rosa M., Silva I., Nilsen J., Perez M.M., Garcia-Segura L.M., Avila J., Naftolin F. Estradiol prevents neural tau hyperphosphorylation characteristic of Alzheimer's disease. Ann. N. Y. Acad. Sci. 2005, 1052:210-224.
4. Appelros P., Stegmayr B., Terent A. Sex differences in stroke epidemiology: a systematic review. Stroke 2009, 40:1082-1090.
5. Barnes L.L., Wilson R.S., Bienias J.L., Schneider J.A., Evans D.A., Bennett D.A. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch. Gen. Psychiatr. 2005, 62:685-691.
6. Barnham K.J., Masters C.L., Bush A.I. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 2004, 3:205-214.
7. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 1997, 51:535-541.
8. Brinton R.D. Requirements of a brain selective estrogen: advances and remaining challenges for developing a NeuroSERM. J. Alzheimer's Dis. 2004, 6:S27-S35.
9. Bryant D.N., Bosch M.A., Rønnekleiv O.K., Dorsa D.M. 17-Beta estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience 2005, 133:343-352.
10. Carlstrom L., Ke Z.J., Unnerstall J.R., Cohen R.S., Pandey S.C. Estrogen modulation of the cyclic AMP response element-binding protein pathway. Effects of long-term and acute treatments. Neuroendocrinology 2001, 74:227-243.
11. Carroll J.C., Rosario E.R., Chang L., Stanczyk F.Z., Oddo S., LaFerla F.M., Pike C.J. Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice. J. Neurosci. 2007, 27:13357-13365.
12. Chae H.S., Bach J.H., Lee M.W., Kim H.S., Kim Y.S., Kim K.Y., Choo K.Y., Choi S.H., Park C.H., Lee S.H., Suh Y.H., Kim S.S., Lee W.B. Estrogen attenuates cell death induced by carboxy-terminal fragment of amyloid precursor protein in pc12 through a receptor-dependent pathway. J. Neurosci. Res. 2001, 65:403-407.
13. Coker L.H., Hogan P.E., Bryan N.R., Kuller L.H., Margolis K.L., Bettermann K., Wallace R.B., Lao Z., Freeman R., Stefanick M.L., Shumaker S.A. Postmenopausal hormone therapy and subclinical cerebrovascular disease: the WHIMS-MRI study. Neurology 2009, 72:125-134.
14. Dubey R.K., Imthurn B., Barton M., Jackson E.K. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc. Res. 2005, 66:295-306.
15. Dumas J., Hancur-Bucci C., Naylor M., Sites C., Newhouse P. Estradiol interacts with the cholinergic system to affect verbal memory in postmenopausal women: evidence for the critical period hypothesis. Horm. Behav. 2008, 53:159-169.
16. Elzer J.G., Muhammad S., Wintermantel T.M., Regnier-Vigouroux A., Ludwig J., Schütz G., Schwaninger M. Neuronal estrogen receptor-alpha mediates neuroprotection by 17beta-estradiol. J. Cereb. Blood Flow Metab. 2010, 30:935-942.
17. Etgen A.M., Jover-Mengual T., Zukin R.S. Neuroprotective actions of estradiol and novel estrogen analogs in ischemia: translational implications. Front. Neuroendocrinol. 2011, 32:336-352.
18. Filardo E.J. Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer. J. Steroid Biochem. Mol. Biol. 2002, 80:231-238.
19. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol. Endocrinol. 2000, 14:1649-1660.
20. Fitzpatrick J.L., Mize A.L., Wade C.B., Harris J.A., Shapiro R.A., Dorsa D.M. Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J. Neurochem. 2002, 82:674-682.
21. Gatson J.W., Liu M.-M., Abdelfattah K., Simpkins J.W., Smith S., Wolf S., Wigginton J.G., Minei J.P. Estrone is neuroprotective in rats following traumatic brain injury. J. Neurotrauma 2012, 29:2209-2219.
22. Goodenough S., Schleusner D., Pietrzik C., Skutella T., Behl C. Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes. Neuroscience 2005, 132:581-589.
23. Green P.S., Simpkins J.W. Role of estrogens and estrogen-like non-feminizing compounds in the prevention and treatment of Alzheimer's disease. Ann. N. Y. Acad. Sci. 2000, 924:93-98.
24. Green P.S., Bishop J., Simpkins J.W. 17 Alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J. Neurosci. 1997, 17:511-515.
25. Green P.S., Gordon K., Simpkins J.W. Phenolic A ring requirement for the neuroprotective effects of steroids. J. Steroid Biochem. Mol. Biol. 1997, 63:229-235.
26. Green P.S., Gridley K.E., Simpkins J.W. Nuclear estrogen receptor-independent neuroprotection by estratrienes: a novel interaction with glutathione. Neuroscience 1998, 84:7-10.
27. Green P.S., Yang S.H., Nilsson K.R., Kumar A.S., Covey D.F., Simpkins J.W. The nonfeminizing enantiomer of 17α-estradiol exerts protective effects in neuronal cultures and a rat model of cerebral ischemia. Endocrinology 2001, 142:400-406.
28. Grodstein F., Manson J.E., Stampfer M.J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J. Women's Health 2006, 15:35-44.
29. Gustafsson J.-Å. What pharmacologists can learn from recent advances in estrogen signaling. Trends Pharmacol. Sci. 2003, 24:479-485.
30. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 2001, 276:36869-36872.
31. Harman S.M. What do hormones have to do with aging? What does aging have to do with hormones?. Ann. N. Y. Acad. Sci. 2004, 1019:299-308.
32. Heldring N., Pike A., Andersson S., Matthews J., Cheng G., Hartman J., Tujague M., Ström A., Treuter E., Warner M., Gustafsson J.-A. Estrogen receptors: how do they signal and what are their targets. Physiol. Rev. 2007, 87:905-931.
33. Hodis H.N., Mack W.J., Azen S.P., Lobo R.A., Shoupe D., Mahrer P.R., Faxon D.P., Cashin-Hemphill L., Sanmarco M.E., French W.J., et al. Hormone therapy and the progression of coronary-artery atherosclerosis in postmenopausal women. N. Engl. J. Med. 2003, 349:535-545.
34. Holst F., Stahl P.R., Ruiz C., Hellwinkel O., Jehan Z., Wendland M., Lebeau A., Terracciano L., Al-Kuraya K., Jänicke F., Sauter G., Simon R. Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat. Genet. 2007, 39:655-660.
35. Hudmon A., Schulman H., Kim J., Maltez J.M., Tsien R.W., Pitt G.S. CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation. J. Cell Biol. 2005, 171:537-547.
36. Hy L.X., Keller D.M. Prevalence of AD among whites: a summary by levels of severity. Neurology 2000, 55:198-204.
37. Ishizawa T., Sahara N., Ishiguro K., Kersh J., McGowan E., Lewis J., Hutton M., Dickson D.W., Yen S.H. Co-localization of glycogen synthase kinase-3 with neurofibrillary tangles and granulovacuolar degeneration in transgenic mice. Am. J. Pathol. 2003, 163:1057-1067.
38. Jezierski M.K., Sohrabji F. Region- and peptide-specific regulation of the neurotrophins by estrogen. Brain Res. Mol. Brain Res. 2000, 85:77-84.
39. Kamp T.J., Hell J.W. Regulation of cardiac L-type calcium channels by protein kinase A and protein kinase C. Circ. Res. 2000, 87:1095-1102.
40. Kanda N., Watanabe S. 17Beta-estradiol inhibits oxidative stress-induced apoptosis in keratinocytes by promoting Bcl-2 expression. J. Invest. Dermatol. 2003, 121:1500-1509.
41. Keay J., Bridgham J.T., Thornton J.W. The Octopus vulgaris estrogen receptor is a constitutive transcriptional activator: evolutionary and functional implications. Endocrinology 2006, 147:3861-3869.
42. Kushner P.J., Agard D.A., Greene G.L., Scanlan T.S., Shiau A.K., Uht R.M., Webb P. Estrogen receptor pathways to AP-1. J. Steroid Biochem. Mol. Biol. 2000, 74:311-317.
43. Levin-Allerhand J.A., Lominska C.E., Wang J., Smith J.D. 17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice. J. Alzheimer's Dis. 2002, 4:449-457.
44. Li W., Huang R.Q., Shetty R.A., Thangthaeng N., Liu R., Chen Z., Sumien N., Rutledge, Dillon G.H., Forster M.J., Simpkins J.W., Yang S.H. Transient focal cerebral ischemia induced long-term cognitive function deficit in an experimental ischemic stroke model. Neurobiol. Dis. 2013, 59:18-25.
45. Liang K., Yang L., Yin C., Xiao Z., Zhang J., Liu Y., Huang J. Estrogen stimulates degradation of beta-amyloid peptide by up-regulating neprilysin. J. Biol. Chem. 2010, 285:935-942.
46. Liu R., Yang S.H., Perez E., Yi K.D., Wu S.S., Eberst K., Prokai L., Prokai-Tatrai K., Cai Z.Y., Covey D.F., Day A.L., Simpkins J.W. Neuroprotective effects of a novel non-receptor-binding estrogen analogue: in vitro and in vivo analysis. Stroke 2002, 33:2485-2491.
47. Liu X.A., Zhu L.Q., Zhang Q., Shi H.R., Wang S.H., Wang Q., Wang J.Z. Estradiol attenuates tau hyperphosphorylation induced by upregulation of protein kinase-A. Neurochem. Res. 2008, 33:1811-1820.
48. Maki P.M. Potential importance of early initiation of hormone therapy for cognitive benefit. Menopause 2006, 13:6-7.
49. Manavathi B., Kumar R. Steering estrogen signals from the plasma membrane to the nucleus: two sides of the coin. J. Cell. Physiol. 2006, 207:594-604.
50. Manaye K.F., Allard J.S., Kalifa S., Drew A.C., Xu G., Ingram D.K., de Cabo R., Mouton P.R. 17Alpha-estradiol attenuates neuron loss in ovariectomized dtg abetapp/ps1 mice. J. Alzheimer's Dis. 2011, 23:629-639.
51. Manson J.E., Allison M.A., Rossouw J.E., Carr J.J., Langer R.D., Hsia J., Kuller L.H., Cochrane B.B., Hunt J.R., Ludlam S.E., Pettinger M.B., Gass M., Margolis K.L., Nathan L., Ockene J.K., Prentice R.L., Robbins J., Stefanick WHI and WHI-CACS Investigators M.L., WHI and WHI-CACS Investigators Estrogen therapy and coronary-artery calcification. N. Engl. J. Med. 2007, 356:2591-2602.
52. Manthey D., Heck S., Engert S., Behl C. Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway. Eur. J. Biochem. / FEBS 2001, 268:4285-4291.
53. Marin R., Guerra B., Morales A., Diaz M., Alonso R. An ICI 182,780-sensitive, membrane-related estrogen receptor contributes to estrogenic neuroprotective actions against amyloid-beta toxicity. Ann. N. Y. Acad. Sci. 2003, 1007:108-116.
54. Miller C.P., Jirkovsky I., Hayhurst D.A., Adelman S.J. In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 1996, 61:305-308.
55. Nilsson S., Mäkelä S., Treuter E., Tujague M., Thomsen J., Andersson G., Enmark E., Pettersson K., Warner M., Gustafsson J.-Å. Mechanisms of estrogen action. Physiol. Rev. 2001, 81:1535-1565.
56. Nord L.C., Sundqvist J., Andersson E., Fried G. Analysis of oestrogen regulation of alpha-, beta- and gamma-secretase gene and protein expression in cultured human neuronal and glial cells. Neuro-degenerative Dis. 2010, 7:349-364.
57. Perez E., Liu R., Yang S.-H., Cai Z.Y., Covey D.F., Simpkins J.W. Neuroprotective effects of an estratriene analog are estrogen receptor independent in vitro and in vivo. Brain Res. 2005, 1038:216-222.
58. Persky R.W., Turtzo L.C., McCullough L.D. Stroke in women: disparities and outcomes. Curr. Cardiol. Rep. 2010, 12:6-13.
59. Petanceska S.S., Nagy V., Frail D., Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Exp. Gerontol. 2000, 35:1317-1325.
60. Petrea R.E., Beiser A.S., Seshadri S., Kelly-Hayes M., Kase C.S., Wolf P.A. Gender differences in stroke incidence and poststroke disability in the framingham heart study. Stroke 2009, 40:1032-1037.
61. Porayette P., Gallego M.J., Kaltcheva M.M., Bowen R.L., Vadakkadath Meethal S., Atwood C.S. Differential processing of amyloid-β precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells. J. Biol. Chem. 2009, 284:23806-23817.
62. Prokai L., Prokai-Tatrai K., Perjesi P., Zharikova A.D., Perez E.J., Liu R., Simpkins J.W. Quinol-based cyclic antioxidant mechanism in estrogen neuroprotection. Proc. Natl. Acad. Sci. USA 2003, 100:11741-11746.
63. Prossnitz E.R., Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol. Cell. Endocrinol. 2009, 308:32-38.
64. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 2008, 70:165-190.
65. Resnick S.M., Espeland M.A., Jaramillo S.A., Hirsch C., Stefanick M.L., Murray A.M., Ockene J., Davatzikos C. Postmenopausal hormone therapy and regional brain volumes: the WHIMS-MRI study. Neurology 2009, 72:135-142.
66. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
67. Richardson T.E., Yang S.-H., Wen Y., Simpkins J.W. Estrogen protection in Friedreich's ataxia skin fibroblasts. Endocrinology 2011, 152:2742-2749.
68. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., Carnethon M.R., Dai S., de Simone G., Ford E.S., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:18-209.
69. Salpeter S.R., Walsh J.M.E., Greyber E., Salpeter E.E. Brief report: coronary heart disease events associated with hormone therapy in younger and older women. A meta-analysis. J. Gen. Int. Med. 2006, 21:363-366.
70. Sarkar S.N., Huang R.-Q., Logan S.M., Yi K.D., Dillon G.H., Simpkins J.W. Estrogens directly potentiate neuronal L-type Ca2+ channels. Proc. Natl. Acad. Sci. 2008, 105:15148-15153.
71. Shelly W., Draper M.W., Krishnan V., Wong M., Jaffe R.B. Selective estrogen receptor modulators: an update on recent clinical findings. Obstet. Gynecol. Surv. 2008, 63:163-181.
72. Simpkins J.W., Rajakumar G., Zhang Y.Q., Simpkins C.E., Greenwald D., Yu C.J., Bodor N., Day A.L. Estrogens reduce mortality and ischemic damage by middle cerebral artery occlusion in the female rat. J. Neurosurg. 1997, 87:724-730.
73. Simpkins J.W., Yi K.D., Perez E., Covey D.F. Structure-nongenomic neuroprotection relationship of estrogens and estrogen-derived compounds. Hormones in Neurodegeneration, Neuroprotection, and Neurogenesis 2011, 13-28. Wiley Publishers. A.G. Gravanis, S.H. Mellon (Eds.).
74. Simpkins J.W., Singh M., Brock C., Etgen A.M. Neuroprotection and estrogen receptors. Neuroendocrinology 2012, 96:119-130.
75. Simpkins J.W., Richardson T.E., YI K.D., Perez E., Covey D.F. Neuroprotection with non-feminizing estrogens. Horm. Behav. 2013, 63:278-283.
76. Singer C.A., Rogers K.L., Dorsa D.M. Modulation of Bcl-2 expression: a potential component of estrogen protection in NT2 neurons. Neuroreport 1998, 9:2565-2568.
77. Singer C.A., Figueroa-Masot X.A., Batchelor R.H., Dorsa D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J. Neurosci. 1999, 19:2455-2463.
78. Singh M., Sétáló G., Guan X., Warren M., Toran-Allerand C.D. Estrogen-induced activation of mitogen-activated protein kinase in cerebral cortical explants: convergence of estrogen and neurotrophin signaling pathways. J. Neurosci. 1999, 19:1179-1188.
79. Sohrabji F., Miranda R.C., Toran-Allerand C.D. Identification of a putative estrogen response element in the gene encoding brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 1995, 92:11110-11114.
80. Sontag E., Luangpirom A., Hladik C., Mudrak I., Ogris E., Speciale S., White C.L. Altered expression levels of the protein phosphatase 2A ABalphaC enzyme are associated with Alzheimer disease pathology. J. Neuropathol. Exp. Neurol. 2004, 63:287-301.
81. Stoltzner S.E., Berchtold N.C., Cotman C.W., Pike C.J. Estrogen regulates Bcl-x expression in rat hippocampus. Neuroreport 2001, 12:2797-2800.
82. Tamrazi A., Carlson K.E., Katzenellenbogen J.A. Molecular sensors of estrogen receptor conformations and dynamics. Mol. Endocrinol. 2003, 17:2593-2602.
83. Towfighi A., Saver J.L., Engelhardt R., Ovbiagele B. A midlife stroke surge among women in the United States. Neurology 2007, 69:1898-1904.
84. Valles S.L., Borras C., Gambini J., Furriol J., Ortega A., Sastre J., Pallardo F.V., Vina J. Oestradiol or genistein rescues neurons from amyloid beta-induced cell death by inhibiting activation of p38. Aging Cell 2008, 7:112-118.
85. Walf A.A., Paris J.J., Rhodes M.E., Simpkins J.W., Frye C.A. Divergent mechanisms for trophic actions of estrogens in the brain and peripheral tissues. Brain Res. 2011, 1379:119-136.
86. Wen Y., Yang S., Liu R., Brun-Zinkernagel A.M., Koulen P., Simpkins J.W. Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like Tauopathy in female rats. J. Biol. Chem. 2004, 279:22684-22692.
87. Xu H., Gouras G.K., Greenfield J.P., Vincent B., Naslund J., Mazzarelli L., Fried G., Jovanovic J.N., Seeger M., Relkin N.R., et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat. Med. 1998, 4:447-451.
88. Yi K.D., Perez E., Yang S.-H., Liu R., Covey D.L., Simpkins J.W. The assessment of non-feminizing estrogens for use in neuroprotection. Brain Res. Rev. 2011, 1379:61-70.
89. Yue X., Lu M., Lancaster T., Cao P., Honda S., Staufenbiel M., Harada N., Zhong Z., Shen Y., Li R. Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model. Proc. Natl. Acad. Sci. USA 2005, 102:19198-19203.
90. Zhang Y., Tounekti O., Akerman B., Goodyer C.G., LeBlanc A. 17-Beta-estradiol induces an inhibitor of active caspases. J. Neurosci. 2001, 21:1-6. (Online).
91. Zhang Q.G., Wang R., Khan M., Mahesh V., Brann D.W. Role of Dickkopf-1, an antagonist of the Wnt/beta-catenin signaling pathway, in estrogen-induced neuroprotection and attenuation of tau phosphorylation. J. Neurosci. 2008, 28:8430-8441.
92. Zhao L., Yao J., Mao Z., Chen S., Wang Y., Brinton R.D. 17Beta-estradiol regulates insulin-degrading enzyme expression via an ERbeta/PI3-K pathway in hippocampus: relevance to Alzheimer's prevention. Neurobiol. Aging 2011, 32:1949-1963.
93. Zheng H., Xu H., Uljon S.N., Gross R., Hardy K., Gaynor J., Lafrancois J., Simpkins J., Refolo L.M., Petanceska S., et al. Modulation of A(beta) peptides by estrogen in mouse models. J. Neurochem. 2002, 80:191-196.